Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Moodys
Baxter
Mallinckrodt
Boehringer Ingelheim

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Custirsen


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Custirsen?

Custirsen is an investigational drug.

There have been 12 clinical trials for Custirsen. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2010.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Lung Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are Achieve Life Sciences, OncoGenex Technologies, and NCIC Clinical Trials Group.

Recent Clinical Trials for Custirsen
TitleSponsorPhase
Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac RepolarizationTeva Branded Pharmaceutical Products R&D, Inc.Phase 1
Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac RepolarizationTeva Pharmaceutical IndustriesPhase 1
Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac RepolarizationAchieve Life SciencesPhase 1

See all Custirsen clinical trials

Clinical Trial Summary for Custirsen

Top disease conditions for Custirsen
Top clinical trial sponsors for Custirsen

See all Custirsen clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Moodys
Baxter
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.